10x Genomics (NASDAQ: TXG) revenue
10x Genomics reported revenue of $642.8m for fiscal 2025, 5.2% more than in fiscal 2024 ($610.8m). Since fiscal 2018 its revenue has grown by 339.3%, an average growth of 23.5% a year.
Fiscal 2025 is the highest of the 8 fiscal years on record for 10x Genomics. The biggest drop was in fiscal 2024, −1.3%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $642.8m | +5.2% | −$61.0m | −9.5% |
| 2024 | $610.8m | −1.3% | −$194.6m | −31.9% |
| 2023 | $618.7m | +19.8% | −$265.3m | −42.9% |
| 2022 | $516.4m | +5.3% | −$167.9m | −32.5% |
| 2021 | $490.5m | +64.1% | −$52.3m | −10.7% |
| 2020 | $298.8m | +21.5% | −$534.1m | −178.7% |
| 2019 | $245.9m | +68.1% | −$30.6m | −12.4% |
| 2018 | $146.3m | — | −$110.8m | −75.7% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
10x Genomics revenue compared with its sector
By revenue for its latest fiscal year, 10x Genomics ranks 180th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; 10x Genomics, 5.2%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 178th | Ultragenyx Pharmaceutical | $673.0m | 20.2% |
| 179th | Doximity | $644.9m | 13.1% |
| 180th | 10x Genomics | $642.8m | 5.2% |
| 181st | TG Therapeutics | $616.3m | 87.3% |
| 182nd | OPKO Health | $606.9m | −14.9% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of 10x Genomics
- How much revenue did 10x Genomics make in fiscal 2025?
- 10x Genomics reported revenue of $642.8m for fiscal 2025, compared with $610.8m in fiscal 2024.
- How much has the revenue of 10x Genomics grown?
- Between fiscal 2018 and fiscal 2025 it went from $146.3m to $642.8m: 339.3% more, an average growth of 23.5% a year.
- What was the best year for revenue at 10x Genomics?
- Of its last 8 fiscal years, fiscal 2025, with $642.8m.
- Where does 10x Genomics rank in its sector by revenue?
- It ranks 180th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for 10x Genomics come from?
- From the annual report (Form 10-K) that 10x Genomics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that 10x Genomics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018. More on 10x Genomics: the 10x Genomics page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.